Yupeng Li

Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib

Xiaomei Ren, Xiaofen Pan, Zhang Zhang et al. · Journal of Medicinal Chemistry · 2013 · 181 citations · Full text

Medicine, Oncology, Pharmacology +13

Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses

Lutz Nuhn, Stefaan De Koker, Sandra Van Lint et al. · Advanced Materials · 2018 · 160 citations

Life Sciences, Immunology, Oncology +17

Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer

Li Zhang, Yiming Zhang, Chengdi Wang et al. · Signal Transduction and Targeted Therapy · 2022 · 113 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Loss of eIF4E Phosphorylation Engenders Depression-like Behaviors via Selective mRNA Translation

Inês S. Amorim, Sonal Kedia, Stella Kouloulia et al. · Journal of Neuroscience · 2018 · 86 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations

Chuan Zhou, Zisheng Fan, Zehui Zhou et al. · Journal of Medicinal Chemistry · 2022 · 81 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +10